Miles Capital’s BioTelemetry, Inc. BEAT Stock Holding History

Miles Capital’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-6,894	Closed	-$432K	–	208
2019 Q1	$432K	Sell	6,894 -1,112	-14%	-$76.4K	0.37%	73
2018 Q4	$478K	Buy	8,006 +152	+2%	+$9.13K	0.47%	65
2018 Q3	$506K	Sell	7,854 -1,323	-14%	-$73.8K	0.41%	64
2018 Q2	$413K	Hold	9,177	–	–	0.25%	79
2018 Q1	$285K	Buy	+9,177	New	+$302K	0.16%	127

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Miles Capital's BEAT Position: Q2 2019 in Review

Miles Capital sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 6,894 shares — an estimated $432K sold.

Miles Capital first reported a position in BEAT in Q1 2018 and held it in 5 quarters. The position peaked at $506K in Q3 2018. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

Miles Capital reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
Miles Capital sold 6,894 BioTelemetry, Inc. shares in Q2 2019, an estimated $432K.
Miles Capital first reported a position in BioTelemetry, Inc. in Q1 2018 and held it in 5 quarters.
Miles Capital's BioTelemetry, Inc. position peaked at $506K in Q3 2018.
251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Miles Capital's 13F filing for Q2 2019, filed 13 Aug 2019.